WO1997025052B1 - Compositions comprising pvp having an average molecular weight in the range of 3,000 to 14,000 daltons - Google Patents

Compositions comprising pvp having an average molecular weight in the range of 3,000 to 14,000 daltons

Info

Publication number
WO1997025052B1
WO1997025052B1 PCT/GB1997/000069 GB9700069W WO9725052B1 WO 1997025052 B1 WO1997025052 B1 WO 1997025052B1 GB 9700069 W GB9700069 W GB 9700069W WO 9725052 B1 WO9725052 B1 WO 9725052B1
Authority
WO
WIPO (PCT)
Prior art keywords
pvp
compositions
daltons
range
average molecular
Prior art date
Application number
PCT/GB1997/000069
Other languages
French (fr)
Other versions
WO1997025052A3 (en
WO1997025052A2 (en
Filing date
Publication date
Priority claimed from GBGB9600426.2A external-priority patent/GB9600426D0/en
Application filed filed Critical
Priority to JP52499597A priority Critical patent/JP4245192B2/en
Priority to EP97900318A priority patent/EP0873130B1/en
Priority to DE69728376T priority patent/DE69728376T2/en
Priority to CA002242618A priority patent/CA2242618C/en
Priority to US09/091,228 priority patent/US6080397A/en
Publication of WO1997025052A2 publication Critical patent/WO1997025052A2/en
Publication of WO1997025052A3 publication Critical patent/WO1997025052A3/en
Publication of WO1997025052B1 publication Critical patent/WO1997025052B1/en

Links

Abstract

The present invention relates to compositions for use in medicine, e.g. as infusion or surgical rinse solutions, and to processes for their preparation. The compositions of the invention comprise an aqueous solution of physiologically inert PVP having a weight average molecular weight in the range of from 3,000 to 14,000 daltons.

Claims

AMENDED CLAIMS
[received by the International Bureau on 21 October 1997 (21.10.97); original claim 12 amended; remaining claims unchanged (1 page)]
10. Use of a composition as claimed in any one of claims 1 to 8 in the manufacture of an infusion, haemodilution or surgical rinse solution.
11. A method of infusion or surgical rinsing of tissues of the human or non-human animal body whereby the tissues are perfused with a composition as claimed in any one of claims l to 8.
12. A process for the preparation of an aqueous solution of physiologically inert PVP as defined in claim 1, said process comprising the step of passing a PVP solution over a cation exchange resin, optionally followed by ultrafiltration.
13. A process as claimed in claim 12 wherein said cation exchange resin is a strong acid cation exchanger.
14. A process as claimed in claim 12 or claim 13 wherein ultrafiltration is carried out at a pressure of from 100 to 500 mm Hg.
15. A PVP solution obtainable by a process as claimed in any one of claims 12 to 14.
PCT/GB1997/000069 1996-01-10 1997-01-09 Compositions comprising pvp having an average molecular weight in the range of 3,000 to 14,000 daltons WO1997025052A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP52499597A JP4245192B2 (en) 1996-01-10 1997-01-09 A composition comprising PVP having an average molecular weight of 3,000 to 14,000 daltons
EP97900318A EP0873130B1 (en) 1996-01-10 1997-01-09 Compositions comprising pvp having an average molecular weight in the range of 7.000 to 12.000 daltons
DE69728376T DE69728376T2 (en) 1996-01-10 1997-01-09 COMPOSITIONS CONTAINING PVP WITH A MEDIUM MOLECULAR WEIGHT OF 7000 TO 12000 DALTONS
CA002242618A CA2242618C (en) 1996-01-10 1997-01-09 Compositions comprising ultrapure pvp having an average molecular weight in the range of 7,000 to 12,000 daltons
US09/091,228 US6080397A (en) 1996-01-10 1997-01-09 Compositions comprising PVP having an average molecular weight in the range of 3.000 to 14.000 daltons

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9600426.2 1996-01-10
GBGB9600426.2A GB9600426D0 (en) 1996-01-10 1996-01-10 Compositions

Publications (3)

Publication Number Publication Date
WO1997025052A2 WO1997025052A2 (en) 1997-07-17
WO1997025052A3 WO1997025052A3 (en) 1997-12-18
WO1997025052B1 true WO1997025052B1 (en) 1998-01-15

Family

ID=10786817

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1997/000069 WO1997025052A2 (en) 1996-01-10 1997-01-09 Compositions comprising pvp having an average molecular weight in the range of 3,000 to 14,000 daltons

Country Status (7)

Country Link
US (1) US6080397A (en)
EP (1) EP0873130B1 (en)
JP (1) JP4245192B2 (en)
DE (1) DE69728376T2 (en)
ES (1) ES2218652T3 (en)
GB (1) GB9600426D0 (en)
WO (1) WO1997025052A2 (en)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060199811A1 (en) * 1997-07-31 2006-09-07 Pfirrmann Rolf W Method of treatment for preventing or reducing tumor growth in the liver of patient
US6479481B1 (en) * 1999-06-04 2002-11-12 Ed. Geistlich Soehne Ag Fur Chemische Industrie Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS)
US8304390B2 (en) 1997-07-31 2012-11-06 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Method of treatment for preventing or reducing tumor growth in the liver of patient
US20050124608A1 (en) * 2001-04-03 2005-06-09 Redmond H. P. Treatment of cancers
US20030027818A1 (en) * 2001-04-03 2003-02-06 Redmond H. Paul Treatment of cancers
US5972933A (en) * 1998-01-08 1999-10-26 Ed. Geistlich Sohne Ag Fur Chemische Industrie Method of treating microbial infections
US20050096314A1 (en) * 2001-04-03 2005-05-05 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of cancers with methylol-containing compounds and at least one electrolyte
US6821968B2 (en) 2001-09-26 2004-11-23 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Stable taurolidine electrolyte solutions
US7345039B2 (en) * 1999-06-04 2008-03-18 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer
US7892530B2 (en) 1999-06-04 2011-02-22 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of tumor metastases and cancer
US8030301B2 (en) * 1999-06-04 2011-10-04 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of cancers with methylol-containing compounds and at least one electrolyte
CN100519525C (en) * 1999-12-06 2009-07-29 葛兰素集团有限公司 Aromatic sulfones and their medical use
DE60030770T2 (en) 1999-12-06 2007-09-06 Rhode Island Hospital USE OF TAUROLIDINE OR TAURULTAM FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF OVARIAN CARCINOMES
US6500408B2 (en) 2001-01-27 2002-12-31 Jc Technologies, Inc. Enamel-safe tooth bleach and method for use
US20080171738A1 (en) * 2001-04-03 2008-07-17 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of Breast Cancer
JP5280603B2 (en) 2001-10-01 2013-09-04 ガイストリッヒ ファーマ アーゲー Methods for metastasis inhibition
US7004756B2 (en) * 2003-01-24 2006-02-28 Ultradent Products, Inc. Pre-shaped dental trays and treatment devices and methods that utilize such dental trays
US6964571B2 (en) 2003-01-24 2005-11-15 Ultradent Products, Inc. Pre-shaped dental trays and treatment devices and methods that utilize such dental trays
AU2004201264B2 (en) * 2003-03-28 2009-12-24 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Adhesive Antineoplastic Compositions
US6860736B2 (en) * 2003-05-23 2005-03-01 Ultradent Products, Inc. Oral treatment devices that include a thin, flexible barrier layer and an endoskeleton treatment or adhesive composition
US7074042B2 (en) * 2003-05-27 2006-07-11 Ultradent Products, Inc. Tray-like dental bleaching devices having a barrier layer and a substantially solid bleaching composition
US7040897B2 (en) * 2003-05-23 2006-05-09 Ultradent Products, Inc. Thin, flexible membrane dental trays and systems and methods utilizing such trays
US7056118B2 (en) * 2003-05-27 2006-06-06 Ultradent Products, Inc. Compositions and devices having a tray-like configuration for delivering a medicament and methods of manufacturing and using such compositions and devices
US7059857B2 (en) * 2003-05-27 2006-06-13 Ultradent Products, Inc. Substantially solid desensitizing compositions and devices having a tray-like configuration and methods of manufacturing and using such compositions and devices
US7011523B2 (en) * 2003-10-22 2006-03-14 Ultradent Products, Inc. Bleaching compositions and devices having a solid adhesive layer and bleaching gel adjacent thereto
US7052275B2 (en) 2003-05-27 2006-05-30 Ultradent Products, Inc. Kits and methods for bleaching and desensitizing teeth
US7048543B2 (en) 2003-05-27 2006-05-23 Ultradent Products, Inc. Substantially solid bleaching composition in a tray-like configuration
US6981874B2 (en) * 2003-10-22 2006-01-03 Ultradent Products, Inc. Dental bleaching compositions and devices having a solid activation adhesive layer or region and bleaching gel layer or region
US6997708B2 (en) * 2003-10-22 2006-02-14 Ultradent Products, Inc. Treatment compositions and strips having a solid adhesive layer and treatment gel adjacent thereto
US7192280B2 (en) * 2004-02-19 2007-03-20 Ultradent Products, Inc. Dental bleaching devices having a protective adhesive region
US7059858B2 (en) 2004-02-19 2006-06-13 Ultradent Products, Inc. Universal tray design having anatomical features to enhance fit
US7264471B2 (en) 2004-05-05 2007-09-04 Ultradent Products, Inc. Methods and kits for bleaching teeth while protecting adjacent gingival tissue
US7625210B2 (en) * 2004-08-09 2009-12-01 Ultradent Products, Inc. Treatment devices for providing oral treatments and kits and methods that utilize such treatment devices
US7696182B2 (en) 2004-11-02 2010-04-13 Nd Partners, Llc Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
US20060171905A1 (en) * 2005-01-31 2006-08-03 Allred Peter M Dental bleaching compositions having a protective coating applied thereto
DE102005005974A1 (en) 2005-02-09 2006-08-10 Basf Ag Process for the stabilization of polyvinylpyrrolidones
US7452209B2 (en) 2005-05-02 2008-11-18 Ultradent Products, Inc. Exoskeleton support for placement of a dental treatment strip
US8007277B2 (en) 2006-08-25 2011-08-30 Ultradent Products, Inc. Non-custom dental treatment trays and mouth guards having improved anatomical features
US20100028829A1 (en) 2008-07-31 2010-02-04 Ultradent Products, Inc. Chemically activated dental bleaching trays
US8202091B2 (en) * 2007-08-31 2012-06-19 Ultradent Products, Inc. Dental treatment trays comprising silicone elastomeric material
DE202009000692U1 (en) 2008-11-04 2009-04-16 Basf Se packaging form
CN102271915B (en) 2008-11-04 2014-11-26 巴斯夫欧洲公司 Use of composite films as a packaging material for oxidation-sensitive polymers, method for packaging oxidation-sensitive polymers, and packaging forms containing said composite films
US8623978B2 (en) 2010-11-23 2014-01-07 Basf Se Process for the preparation of low-peroxide crosslinked vinyllactam polymer
EP2511331A1 (en) 2011-04-12 2012-10-17 Basf Se Low peroxide phosphorous compound contained polymers
US9023931B2 (en) 2011-04-12 2015-05-05 Basf Se Oxidation-sensitive, low-peroxide polymer comprising at least one inorganic phosphorus compound
DE202011005055U1 (en) 2011-04-12 2011-09-12 Basf Se Low-peroxide polymer containing phosphorus compound
WO2012140561A1 (en) 2011-04-12 2012-10-18 Basf Se Oxidation-sensitive, low-peroxide polymer comprising at least one inorganic phosphorus compound
BR112015002465B1 (en) 2012-08-08 2021-01-19 Basf Se process for the production of a lactam vinyl polymer, lactam vinyl polymer obtainable by the process, use of the polymer, membrane for purifying liquids and hair gel
US9260546B2 (en) 2012-08-08 2016-02-16 Basf Se Producing aqueous solutions of vinyllactam polymers and powders thereof
WO2018175777A1 (en) * 2017-03-22 2018-09-27 Cormedix Inc. Use of an injectable antimicrobial composition for the prevention and/or treatment of osteoarthritis
US11738120B1 (en) 2022-04-14 2023-08-29 Cormedix Inc. Synthesis of taurolidine, purity profiles and polymorphs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4350156A (en) * 1980-05-29 1982-09-21 Japan Foundation For Artificial Organs Method and apparatus for on-line filtration removal of macromolecules from a physiological fluid
GB8328074D0 (en) * 1983-10-20 1983-11-23 Geistlich Soehne Ag Chemical compositions
GB8328111D0 (en) * 1983-10-20 1983-11-23 Geistlich Soehne Ag Chemical compounds
GB8426922D0 (en) * 1984-10-24 1984-11-28 Sandoz Ltd Galenic formulation

Similar Documents

Publication Publication Date Title
WO1997025052B1 (en) Compositions comprising pvp having an average molecular weight in the range of 3,000 to 14,000 daltons
WO1997025052A3 (en) Compositions comprising pvp having an average molecular weight in the range of 3,000 to 14,000 daltons
JPH08510454A (en) Anti-infective drug
CA2392284A1 (en) Medical device
CN100562307C (en) A kind of antibiotic toothpaste and manufacture method thereof
CA2236262A1 (en) Room temperature sterilant for medical devices
WO2001021159A3 (en) Pharmaceutical composition of nateglinide and another antidiabetcagent
CA2301577A1 (en) Glucose-containing preparation
CA2250819A1 (en) Solution for transperitoneal dialysis
EP2767291A3 (en) Treatment of glycogen storage disease type II
CA2147281A1 (en) Method and compositions for removing an alginate from a cutaneous substrate
CN114224771B (en) No-wash hand cleanser and preparation method thereof
CN106215239B (en) A kind of preparation method of crosslinked antimicrobial type acellular matrix material
CN109453411B (en) Chitosan dressing
CN113968984B (en) Preparation method of safe and long-acting multifunctional wound dressing
EP1402871B1 (en) Antithrombotic compositions and medical instruments containing the same
CA2347447A1 (en) Buffered compositions for dialysis
CN113144281B (en) Wound surface disinfection gel and preparation method thereof
CN111632188A (en) Seaweed polysaccharide composite biological matrix dressing and preparation method thereof
US20040213753A1 (en) Method for stimulating cell growth using sponge protein hydrolysates
MXPA01007210A (en) Therapeutic agent for parkinson's disease including function improving agent for astrocyte.
SU1814764A3 (en) Method of preparing of agent for purulent-necrotic wound treatment
JPH03261643A (en) Curable composition
CA2242618A1 (en) Compositions comprising ultrapure pvp having an average molecular weight in the range of 7,000 to 12,000 daltons
RU2028158C1 (en) Composition for wound surface covering